strangvac
intervacc ab - recombinant streptococcus equi protein cce, recombinant streptococcus equi protein eq85, recombinant streptococcus equi protein idee - immunologische tests für equiden - pferde - for the active immunisation to reduce clinical signs and the number of abscesses in acute stage of infection with s. equi.
systamex intervall-bolus ad us. vet. systamex intervall-bolus ad us. vet.
msd animal health gmbh - oxfendazolum - systamex intervall-bolus ad us. vet. - oxfendazolum 750 mg, excipiens pro compresso. - synthetika
atorvastatin bluefish ab 10 mg filmtabletten
bluefish pharmaceuticals ab - atorvastatin calcium trihydrat -
atorvastatin bluefish ab 20 mg filmtabletten
bluefish pharmaceuticals ab - atorvastatin calcium trihydrat -
atorvastatin bluefish ab 40 mg filmtabletten
bluefish pharmaceuticals ab - atorvastatin calcium trihydrat -
atorvastatin bluefish ab 80 mg filmtabletten
bluefish pharmaceuticals ab - atorvastatin calcium trihydrat -
alprolix
swedish orphan biovitrum ab (publ) - eftrenonacog alfa - hämophilie b - vitamin k und andere hämostatika, blut-gerinnungsfaktoren - behandlung und prophylaxe von blutungen bei patienten mit hämophilie b (angeborener faktor ix-mangel).
sedaconda 100 % v/v flüssigkeit zur herstellung eines dampfs zur inhalation
sedana medical ab (1007036) - isofluran - flüssigkeit zur herstellung eines dampfs zur inhalation - 100 % v/v - isofluran (21975) 100 prozentgehalt volumen in masse
systamex intervall-bolus forte ad us. vet. systamex intervall-bolus forte ad us. vet.
msd animal health gmbh - oxfendazolum - systamex intervall-bolus forte ad us. vet. - oxfendazolum 1'250 mg, color.: e 132, excipiens pro compresso. - synthetika
ayvakyt
blueprint medicines (netherlands) b.v. - avapritinib - gastrointestinale stromatumoren - andere antineoplastische wirkstoffe, die protein-kinase-inhibitoren - ayvakyt is indicated as monotherapy for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumours (gist) harbouring the platelet-derived growth factor receptor alpha (pdgfra) d842v mutation.